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system towards or away from the isocentre position, which is 
defined by the isocentre of the MRI scanner. The rail system 
enables the linatron to be placed at 8 different positions 
from the linatron ranging from a SSD of 190-336cm. To verify 
alignment of the radiation beam for the different linac rail 
positions, radiation profiles were acquired in air at different 
distances from the target. From the profiles the central axis 
position (CAX) was used to establish the alignment of the 
radiation beam. To verify MLC alignment to the CAX without 
the ability to rotate the collimator, a series of half blocked 
fields were used, with abutting fields and picket fence tests 
used to verify positional accuracy. Standard scanning water 
tank systems can not be used within the MRI scanner due to 
both ferromagnetic components and lack of physical space. 
To enable a comparison of baseline data once the magnet is 
installed, water dosimetry measurements were compared 
with measurements within an adjustable solid water 
phantom. 
 
Results: CAX measurements were successfully used to 
establish the alignment of the radiation beam for different 
linac positions. The reproducibility of the central position of 
the radiation beam was within 2 mm for all positions and the 
radiation beam alignment for all positions was within 0.5 
degrees, demonstrating that the radiation beam was 
horizontal and not misaligned within that plane. MLC 
alignment was within 0.5mm of the CAX beam position at a 
source to surface distance (SSD) of 100cm and within 6.5mm 
at a SSD of 277cm. The solid water phantom set-up achieved 
comparable dosimetry with the water tank set-up, enabling 
future measurements to be undertaken safely within the 
confines of the MRI scanner. 
 
Conclusion: We have developed a generalised methodology 
appropriate for the commissioning a fixed radiation therapy 
beam line. We have taken baseline (no magnetic field) 
alignment and dosimetry measurements for the AMP 
beamline, demonstrating that the rail system and MLC 
alignment are within tolerance. We have also demonstrated 
the equivalency of a solid water approach with a 
conventional water tank enabling future dosimetry 
measurements within the MRI scanner.  
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Purpose or Objective: Interobserver contouring variability is 
one of the most important sources of uncertainty in 
radiotherapy. Blended learning techniques are formal 
educational programs in which students learn, at least in 
part, through delivery of content and instruction via digital 
and online media with some element of student control over 
time, place, path, or pace. In 2009, ESTRO launched the 
FALCON (Fellowship in Anatomic deLineation and CONtouring) 
project. This web-based project aims at the improvement of 
the skills and homogeneity in contouring among professionals 
and/or trainees in the field of radiation oncology by 
organizing live and online contouring workshops. This study 
reports the first results of interactive teaching during live 
workshops. 
 
Material and Methods: We analyzed the contours of 66 
participants to 2 live FALCON workshops and covering 2 
clinical situations: the contouring of prostate cancer (35 
participants) and the contouring of some Organs At Risks 
(OARs - brachial plexus, esophagus, trachea and proximal 
bronchial tree, 31 participants). In all the analysed 
workshops, delineations were done before and after 
interactive teaching. Variability of clinical target volumes 
(CTVs) contoured by participants and the impact of teaching 
courses was evaluated using the DICE indexes. Moreover, for 
the prostate case, 3 sub-regions were retrospectively 
identified and analyzed separately : the prostate base (upper 
5 slices, total length: 1 cm), the mid-prostate (following 15 
consecutive slices) and the prostate apex (five lower slices, 
total length: 1 cm). 
 
Results: Table 1 summarizes data of the 2 workshops. Mean 
CTV DICE indices for the workshops ranged overall from 15% 
to 84.1% before the teaching lecture, and from 23.4% to 
86.1% after teaching, but with large interobserver variations. 
Usually, a significant improvement in delineation was 
observed on DICE indices among participants compared to 
experts' delineations after the teaching lecture (two-tailed t-
test P value ranging between 0.04 and <0.001). An 
improvement was also noted at a more qualitative analysis, 
with the contours being much more homogeneous amongst 
participants after teaching.  
 
 
Conclusion: Evaluation of the immediate impact of teaching 
contouring is feasible and FALCON teaching methods reduce 
interobserver variability in CTV delineation at workshops. 
ESTRO is strongly committed in the further development of 
the current and of the future live and online FALCON 
workshops. The long-term impact of the FALCON workshops 
will be further evaluated in the context of well designed ad 
hoc research projects. 
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Purpose or Objective: To assess the safety, feasibility and 
efficacy of free-hand intra-operative multi-catheter breast 
implant and peri-operative high-dose rate brachytherapy 
(FHIOMBI-PHDRBT program) in early breast cancer treated by 
breast conservative surgery (BCS). 
 
Material and Methods: Patients with early breast cancer who 
were candidates for BCS and potential accelerated partial 
breast irradiation (APBI) were prospectively enrolled for the 
FHIOMBI-PHDRBT program. Patients suitable for APBI received 
PHDRBT (3.4 Gy BID for 10 in five days). Patients not suitable 
for APBI received PHDRBT as anticipatory boost (3.4 Gy BID 
for 4 in two days) followed by whole breast irradiation (WBI).  
 
Results: From November 2008 to January 2015, a total of 119 
patients were treated and 122 FHIOMBI procedures were 
performed. Median duration of FHIOMBI was 25 minutes. A 
median of 8 catheters (range 4-14) were employed. No 
intraoperative complications were observed. Severe early 
postoperative complications (bleeding) were documented in 2 
patients (1.6%), wound healing complications in 3 (2.4%), and 
infection (mastitis or abscess) in 2 (1.6%). Late mammogram 
follow-up revealed oil cysts in 56% of patients but 
symptomatic fat necrosis in only 2 patients (1.6%). PHDRBT 
was delivered as APBI in 88 patients (74%) and as a boost in 
31 (26%). The median CTV-T was 40.8 cc (range 12.3-160.5), 
median D90 of 3.32 Gy (range 3.11-3.85), median DHI 0.72 
(range 0.48-0.82) median D10 in high-risk skin zone 1.94 Gy 
(range 0.92-3.37). With a median follow-up of 35 months 
(range 5.9-80.9) in the whole group and 37.7 months (range 
7.6-80.9) in APBI patients, no local, elsewhere or regional 
failures were observed, only one distant failure in PHDRBT 
boost was documented. Cosmetic outcomes were evaluated 
in APBI patients as excellent (42.0%), very good (46.0%), fair 
(10.0%) or poor (2.0%). 
 
Conclusion: The FHIOMBI-PHDRBT program does not add 
complications to conservative surgery, it adapts to breast 
size and location of the tumor, fulfilling at the same time 
prescription requirements and constraints. It allows an 
exquisite selection of APBI patients and offers excellent 
results in disease control and cosmetics. It also offers logistic 
advantages as it dramatically shortens the time of local 
treatment and avoids further invasive procedures. 
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Purpose or Objective: To describe early observations of a 
multi-center study utilizing a single fraction of intra-
operative radiation therapy (IORT) using the Xoft® Axxent® 
Electronic Brachytherapy System® (eBx®) immediately 
following surgical resection of early stage breast cancer. 
 
Material and Methods: 727 subjects have been treated at 25 
hospitals. Upon meeting entry criteria, patients underwent 
partial mastectomy. While in the operating room a balloon 
applicator was placed in the lumpectomy cavity and inflated 
with saline (30–75 cc). The skin was closed over the balloon, 
a balloon surface-to-skin distance of >1.0 cm was confirmed, 
and a single fraction of IORT was delivered to the 
lumpectomy cavity. The prescribed dose was 20 Gy at the 
balloon applicator surface; the mean treatment time was 
10.3 minutes. After treatment, the balloon was deflated and 
removed, and skin sutured. 
 
Results: 726 subjects received the prescribed dose of 20 Gy; 
one received 21 Gy. 56 are removed from the primary 
analysis post-IORT due to subsequent whole breast irradiation 
(N=37), positive lymph nodes (N=7), positive surgical margins 
(N=4), re-excision (N=4), inadequate skin bridge (N=2), 
inadequate balloon conformance (N=1), and other (N=4). 
These subjects will be followed for the duration of the study. 
An additional 60 subjects have withdrawn, leaving 667 active 
subjects. The mean patient age is 65 years (44-88). 148 
subjects (20%) had ductal carcinoma in situ, 550 (75%) had 
invasive ductal carcinoma, 28 (5%) were unknown. DCIS 
nuclear grade was high (N=55), intermediate (N=64) and low 
(N=27); 2 were unknown. Invasive cancer was Grade 1-2 in 
465/550 cases. 93% (N=676) had T1 lesions, 7% (N=51) had T2 
lesions. Mean tumor size is 10.53 mm ± 8.3 mm. Mean follow-
up is 336 days (4-1096). Only 125/926 (13.5%) of the reported 
adverse events were Grade 2 or higher. The most frequent 
AEs are seroma (15.4%), breast pain (14.1%), erythema 
(10.7%), and induration (8.5%). Cosmesis was excellent-to-
good in over half (65%) of the cases. There have been six (6) 
deaths (aortic aneurysm; heart attack; pneumonia; liver 
cancer; 2 unknown causes) and only one (1) recurrence 
reported to-date. 
 
Conclusion: IORT using the Xoft System as part of the 
conservative treatment of breast cancer is safe, with low 
morbidity. Early results from this multi-center trial 
demonstrate this short, convenient course of radiation 
therapy for select patients with early stage breast cancer has 
excellent-to-good cosmetic results and a low rate of low-
grade adverse events. 
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Purpose or Objective: Purpose: The study we report is for 
early stage breast cancer and is a multicentre clinical 
investigation of PBI achieved by interstitial HDR 
brachytherapy with intraoperative placement of catheters. 
